SYROS PHARMACEUTICALS INC's ticker is and the CUSIP is 87184Q907. A total of 3 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $0 | -100.0% | 200 | -97.5% | 0.00% | – |
| Q4 2021 | $26,000 | -7.1% | 8,000 | +29.0% | 0.00% | – |
| Q3 2021 | $28,000 | -70.8% | 6,200 | -65.0% | 0.00% | – |
| Q2 2021 | $96,000 | -48.4% | 17,700 | -28.9% | 0.00% | – |
| Q1 2021 | $186,000 | +23.2% | 24,900 | +79.1% | 0.00% | – |
| Q4 2020 | $151,000 | +1577.8% | 13,900 | +1290.0% | 0.00% | – |
| Q3 2020 | $9,000 | -40.0% | 1,000 | -28.6% | 0.00% | – |
| Q2 2020 | $15,000 | +650.0% | 1,400 | +250.0% | 0.00% | – |
| Q1 2020 | $2,000 | -33.3% | 400 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | -40.0% | 400 | -20.0% | 0.00% | – |
| Q2 2019 | $5,000 | -98.0% | 500 | -98.1% | 0.00% | -100.0% |
| Q1 2019 | $247,000 | +194.0% | 27,000 | +80.0% | 0.00% | +200.0% |
| Q4 2018 | $84,000 | -54.6% | 15,000 | -3.2% | 0.00% | 0.0% |
| Q3 2018 | $185,000 | +1133.3% | 15,500 | +933.3% | 0.00% | – |
| Q2 2018 | $15,000 | -81.0% | 1,500 | -75.4% | 0.00% | -100.0% |
| Q1 2018 | $79,000 | +216.0% | 6,100 | +134.6% | 0.00% | – |
| Q4 2017 | $25,000 | – | 2,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 28 | $16,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 400 | $2,000 | 0.00% |